Navigation Links
PAP therapy improves neurobehavioral outcomes in children with OSA
Date:2/9/2012

irst to demonstrate that PAP therapy results in significant improvements in a range of neurobehavioral domains in these patients, including those with developmental delays."

The study had several limitations, including the lack of a placebo group, the use of reports from subjects and caregivers only, and the lack of blinding.

"The improvements we observed in daytime sleepiness, attention, internalizing behaviors and quality of life occurred despite a mean use of PAP of only three hours a night," said Dr. Marcus. "This suggests that PAP use should be encouraged in children with OSAS, even in those with suboptimal adherence, as it can lead to improvements in function that can in turn affect family, social and school function."


'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Nanotube therapy takes aim at breast cancer stem cells
2. Combination drug therapy urged to battle lung cancer
3. Sanford-Burnham researchers find molecular switch that allows melanoma to resist therapy
4. Stem Cell Therapy Shows Promise for Stroke, Studies Say
5. ACCF/AATS/SCAI/STS release consensus document to help guide use of minimally invasive heart therapy
6. New target for cancer therapy identified, preclinical study shows
7. Research finds newer radiation therapy technology improves patients quality of life
8. Radiation plus chemotherapy provides long-term positive results for head and neck cancer patients
9. Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds
10. Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
11. Scientists report first step in strategy for cell replacement therapy in Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... (HealthDay News) -- New research suggests that young asthma ... such as ipratropium [Atrovent] -- could be more likely ... However, the increased risk was not seen ... raises concern because of the recent interest in use ... the University of Illinois at Chicago, said in a ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients ... (CAP) is associated with a lower incidence and ... study from researchers in Spain. , A parapneumonic ... fluid that accumulates between the two pleural layers, ... arises as a result of a pneumonia, lung ...
(Date:5/22/2012)... OAK BROOK, Ill. Magnetic resonance imaging (MRI) ... to pre-surgical chemotherapy significantly earlier than possible through ... online in the journal Radiology . ... prior to surgery. Research has shown that women ... are more likely to achieve breast conservation than ...
(Date:5/22/2012)... By Carina Storrs HealthDay Reporter , , TUESDAY, ... treating obstructive sleep apnea, a common cause of snoring ... serious health hazard associated with the condition -- the ... Spain examined the number of new cases of high ... used continuous positive airway pressure therapy, or CPAP, for ...
(Date:5/22/2012)... Researchers at Barrow Neurological Institute at St. Joseph,s ... why the public perceives some magic tricks in ... military tactics, marketing and sports. , Susana Martinez-Conde, ... Stephen Macknik, PhD, of Barrow,s Laboratory of Behavioral ... magic and illusions. Their most recent original research ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... levels of certain cytokines spiked during disease stage , , ... Africa recently had the rare opportunity to follow the ... recovery in a 29-year-old lab worker who had accidentally ... the researchers followed the trajectory of cytokines, a type ...
... ATLANTA Georgia State University and the Georgia Institute ... provide researchers around Atlanta with a dedicated magnetic resonance ... the brain and mind. , The Center for Advanced ... Georgia Tech, opened this month for researchers exploring topics ...
... disease recurrence, death nearly twice that of normal-weight patients ... cancer patients are more likely than non-obese patients to ... say U.S. researchers. , "We identified a subset ... at 12-fold increased risk of lymph node metastasis compared ...
... until Executive Search for Replacement is CompletedPlanned Investor ... at 4:15 PM ET LIVINGSTON, N.J., March ... MLSS), the recognized leader in advanced injection technologies, ... Board, will temporarily assume the post of Interim ...
... The American Academy of Nurse Practitioners (AANP) announces the ... AANP Chief Executive Officer, effective March 20, 2009. ... will retire after 13 years as CEO of AANP. ... in her role as Executive Director of the AANP ...
... Event held in partnership with Children,s Hospital of Michigan ... for vehicle travelProper use of booster seats and car ... road , DETROIT, March 18 Parents and caregivers ... children for vehicle travel during the Second Annual ...
Other Medicine News:Health News:Course of West Nile Infection Charted 2Health News:Course of West Nile Infection Charted 3Health News:Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research 2Health News:Obesity Tied to Poor Pancreatic Cancer Surgery Outcomes 2Health News:Milestone Scientific Announces Resignation of CEO 2Health News:Milestone Scientific Announces Resignation of CEO 3Health News:American Academy of Nurse Practitioners Announces New Chief Executive Officer 2Health News:Wayne County Community College District Presents Second Annual Child Car Seat Check Program 2
(Date:5/23/2012)... -- According to Cold Chain IQ ... excursions in 6% or more of their temperature ... can not only result in product losses, but ... IQ presents a new report examining temperature excursions ... products and leading strategies that the pharmaceutical industry ...
(Date:5/22/2012)... SmallCapVoice.com, Inc. announced today that ... Inc. (PINKSHEETS: MJNA) is now available. The ... . Recent company activity and ... income of approximately $1.21 million on gross ... ended March 31, 2012.  This represents a ...
(Date:5/22/2012)... -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, ... chief financial officer (CFO). DuCharme will lead Prime,s finance ... growth. "Jim brings deep health plan expertise ... within diverse health plans, including Blue Cross and Blue ... Prime. "Based on his strong belief in pharmacy as ...
Breaking Medicine Technology:New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 1Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 2Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 3Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 5Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 6Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 7Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 1Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 2Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 3Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 4Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 5Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 6Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 7Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 1Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 2Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 3
... Survival, Disease Control and Neurotoxicity Data To Be ... Support Picoplatin as a Neuropathy-Sparing Alternative to Oxaliplatin ... Management Team to Host Analyst and Investor Briefing ... SOUTH SAN FRANCISCO, Calif., May 28 Poniard ...
... additional analyses from the Phase II portion of a ... for the treatment of acute heart failure will be ... of the Heart Failure Association of the European Society ... professor of cardiology at the University of Brescia, Italy, ...
Other Medicine Technology:Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 6Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009 2
... onlays are pre-cut and pre-shaped to facilitate ... more frequently done. These pre-shaped onlays are ... Ultra and are designed for use in ... both small and large sizes, they provide ...
... and soft tissue reconstructions, and in ... is sometimes necessary to encourage host ... minimizing tissue attachment along another surface.,GORE ... ePTFE sheet material that offers a ...
... is pleased to announce the latest advancement ... E/X mesh.,When Bard Composix mesh was introduced ... hernia repair prosthesis that combined two clinically ... in one product. Bard Composix E/X mesh, ...
... introduction in 1958, Bard mesh has become ... are compared. Bard mesh was used by ... the "tension-free" hernia repair many years ago. ... and ideal" substance for permanent reinforcement of ...
Medicine Products: